Fremanezumab is a calcitonin-gene related peptide (CGRP) pathway monoclonal antibody that is FDA approved for adults with both episodic and chronic migraine.

On April 12, 1955, the vaccine developed by Jonas Salk and his colleagues was officially declared ‘safe, effective and potent ...

Don't miss our season ticket member emails about exclusive benefits, event invitations, ticket presales, seat relocation or renewals. Make sure to add the below email addresses to your approved ...